vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $22.0M, roughly 1.4× BGSF, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -32.1%, a 26.8% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -9.4%). BGSF, INC. produced more free cash flow last quarter ($1.7M vs $25.0K). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -5.3%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
BGSF vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $31.1M |
| Net Profit | $-1.2M | $-10.0M |
| Gross Margin | 35.0% | 25.0% |
| Operating Margin | -17.6% | -9.9% |
| Net Margin | -5.3% | -32.1% |
| Revenue YoY | -9.4% | -4.5% |
| Net Profit YoY | -18.2% | -52.0% |
| EPS (diluted) | $-0.12 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | — | ||
| Q3 25 | $26.9M | $31.1M | ||
| Q2 25 | $23.5M | — | ||
| Q1 25 | $20.9M | $35.2M | ||
| Q4 24 | $24.3M | $32.6M | ||
| Q3 24 | $29.8M | $24.7M | ||
| Q2 24 | $25.7M | — | ||
| Q1 24 | $24.5M | $35.7M |
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-5.8M | $-10.0M | ||
| Q2 25 | $-3.7M | — | ||
| Q1 25 | $-722.0K | $-14.8M | ||
| Q4 24 | $-981.0K | $-6.6M | ||
| Q3 24 | $-804.0K | $-16.2M | ||
| Q2 24 | $-761.0K | — | ||
| Q1 24 | $-792.0K | $15.6M |
| Q4 25 | 35.0% | — | ||
| Q3 25 | 35.9% | 25.0% | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | 36.2% | 28.0% | ||
| Q4 24 | 35.9% | 34.0% | ||
| Q3 24 | 35.9% | 21.8% | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 38.1% | 33.3% |
| Q4 25 | -17.6% | — | ||
| Q3 25 | -3.5% | -9.9% | ||
| Q2 25 | -18.8% | — | ||
| Q1 25 | 1.6% | -25.7% | ||
| Q4 24 | -15.7% | -6.0% | ||
| Q3 24 | -3.4% | -46.9% | ||
| Q2 24 | -5.7% | — | ||
| Q1 24 | 1.7% | -2.5% |
| Q4 25 | -5.3% | — | ||
| Q3 25 | -21.6% | -32.1% | ||
| Q2 25 | -15.9% | — | ||
| Q1 25 | -3.5% | -42.0% | ||
| Q4 24 | -4.0% | -20.2% | ||
| Q3 24 | -2.7% | -65.7% | ||
| Q2 24 | -3.0% | — | ||
| Q1 24 | -3.2% | 43.8% |
| Q4 25 | $-0.12 | — | ||
| Q3 25 | $-0.52 | $-0.29 | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.06 | $-0.47 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | $-0.07 | $-0.53 | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $48.1M | $-10.5M |
| Total Assets | $57.8M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $41.2M | $18.9M | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $2.0M | $5.4M | ||
| Q4 24 | $32.0K | $9.5M | ||
| Q3 24 | $262 | — | ||
| Q2 24 | $226 | — | ||
| Q1 24 | $50 | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $48.1M | — | ||
| Q3 25 | $50.7M | $-10.5M | ||
| Q2 25 | $78.3M | — | ||
| Q1 25 | $81.8M | $2.2M | ||
| Q4 24 | $82.3M | $15.4M | ||
| Q3 24 | $82.9M | $-3.9M | ||
| Q2 24 | $83.2M | — | ||
| Q1 24 | $83.6M | $17.7M |
| Q4 25 | $57.8M | — | ||
| Q3 25 | $83.6M | $235.2M | ||
| Q2 25 | $149.7M | — | ||
| Q1 25 | $152.3M | $237.7M | ||
| Q4 24 | $150.1M | $255.4M | ||
| Q3 24 | $157.3K | $246.8M | ||
| Q2 24 | $159.8K | — | ||
| Q1 24 | $170.6K | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $1.8M |
| Free Cash FlowOCF − Capex | $1.7M | $25.0K |
| FCF MarginFCF / Revenue | 7.6% | 0.1% |
| Capex IntensityCapex / Revenue | 0.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | — | ||
| Q3 25 | $-4.8M | $1.8M | ||
| Q2 25 | $2.2M | — | ||
| Q1 25 | $1.1M | $1.2M | ||
| Q4 24 | $3.2M | $-6.1M | ||
| Q3 24 | $6.5M | $-613.0K | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $7.4M | $-1.4M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $-4.9M | $25.0K | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $1.0M | $-4.3M | ||
| Q4 24 | $2.5M | $-8.6M | ||
| Q3 24 | $6.5M | $-4.0M | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $6.9M | $-7.8M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | -18.1% | 0.1% | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 5.0% | -12.1% | ||
| Q4 24 | 10.2% | -26.3% | ||
| Q3 24 | 21.7% | -16.3% | ||
| Q2 24 | 28.5% | — | ||
| Q1 24 | 28.1% | -21.8% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | 5.6% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | 15.5% | ||
| Q4 24 | 3.0% | 7.5% | ||
| Q3 24 | 0.0% | 13.9% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.0% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
